Phobia-Phobic Disorders
A phobia is a type of anxiety disorder defined by a persistent and excessive fear of an object or situation. Phobias typically result in a rapid onset of fear and are present for more than six months.
Cluster Number:
Wiki Number: PW166
Diagnosis: Phobia-Phobic Disorders
US Patients: 8.7%-18.1% suffer-may not be patients;
World Patients: Specific-6-8% in Western world; 2-4% Asia, Africa & Latin America; Social-7% US; 0.5-2.5% elsewhere; agoraphobia-1.7%
Sex Ratio: M;W2, Phobias are the most common mental illness-challenge among women.
Age Onset: Ages 10-17; During or after the event lasting 6-months to permanently; 75% of those with phobias have multiple phobias.
Brain Area: Insula involved with the autonomic functions; anterior cingulate cortex, ventromedial prefrontal & medial prefrontal cortexes
Symptoms: an anxiety disorder with persistent and excessive fear of an object or situation. Phobias can be specific, social or agoraphobia-places
Progression: Range from mild concern to panic attacks-lose control over themselves physically.
Causes: Fear conditioning; traumatizing event; observing others who fear; the basolateral amygdala keeps a memory with the hippocampus
Medications: Social phobias-antidepressants, benzodiazepines or beta blockers//EMDR-Eye Movement Desensitization & Reprocessing
Therapies: Specific phobias (such as, spiders, snakes, heights)use-exposure therapy; social phobias-systematic desensitization, relaxation
Youtube Video: Phobias? Why Do We Have Them?
Amazon or Library Book: The Anxiety and Phobia Workbook
Click the book to link or order from Amazon.
Support Group: Facebook-phobiassupportgroup; 609-713-2963 (Phobia Anxiety Support Group)
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Comorbid anxiety disorders in patients with neurological pathology: current state of the problem and the role of etifoxine in treatment strategyby N G Neznanov on December 28, 2024
The article presents theses of the resolution of the Interdisciplinary Council of Experts in Psychiatry and Neurology (Moscow, 2024) on the issue of comorbid anxiety disorders (AD) in patients with neurological pathologies. The authors highlight the high prevalence of comorbid ADs and their significant negative impact on the course of underlying diseases, such as epilepsy, pain syndromes and post-stroke conditions. Modern approaches to the diagnosis and treatment of ADs in this group of patients...
- Attributional Styles and Their Impact on Depressive and Anxious Symptoms in Italian Children: Insights from the Italian Children's Attributional Style Questionnaire-Revised (CASQ-R)by Simona Scaini on December 27, 2024
CONCLUSIONS: The identified classes shed light on distinct patterns associated with depressive and anxious symptoms, offering potential insights for targeted interventions.
- Virtual reality modulating dynamics of neuroplasticity: Innovations in neuro-motor rehabilitationby Nitu L Wankhede on December 26, 2024
Virtual reality (VR) technology has emerged as a ground-breaking tool in neuroscience, revolutionizing our understanding of neuroplasticity and its implications for neurological rehabilitation. By immersing individuals in simulated environments, VR induces profound neurobiological transformations, affecting neuronal connectivity, sensory feedback mechanisms, motor learning processes, and cognitive functions. These changes highlight the dynamic interplay between molecular events, synaptic...
- Prevalence of anxiety disorders among visitors at a military primary health center in UAEby Fayeza Alameri on December 26, 2024
CONCLUSIONS: The prevalence of anxiety disorders was considerably higher among visitors at a Military Primary Health Center due to the high stress levels and occupational difficulties associated with an unstable social and family life. Counseling services and follow-up of diagnosed cases should be available at the primary health care level for improved healthcare delivery by the primary care or family health physicians.